SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

BACKGROUND: Gliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Cell Int
Asıl Yazarlar: Wang, Peng, Zhang, Jingjing, He, Shuai, Xiao, Boan, Peng, Xiaobin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Primary Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694905/
https://ncbi.nlm.nih.gov/pubmed/33292262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01675-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller